• Rohan Pramod Dhumal
• Vikrant Anil Patil
• Shubham Arjun Ghare
• Tejas Popat Desai
• Tejas Rayaba Kheradkar

Mycobacterium tuberculosis, the bacteria that causes tuberculosis (TB), is one of the most common infectious diseases in the world. Treatment and diagnosis of TB remain major public health issues. Ten million people get tuberculosis (TB) every year, and even though it's a preventable and treatable illness, 1.5 million people pass away TB is a particular problem in the aged population due to the coexistence of multiple causes. aging-related immunodeficiency, the possibility of developing new immunodepressive disorders associated with other comorbidities connected to aging, and possible pharmacological interactions between anti- tuberculosis treatments and other prescriptions. Furthermore, there aren't much particular data on tuberculosis in elderly patients.(1) Protective barriers raise the risk of tuberculosis (TB) in this age range by compromising microbial clearance systems, decreasing cellular immune responses to M. tuberculosis, and other ways. Furthermore, aged individuals are particularly vulnerable to both new TB infection and the reactivation of latent TB. Diagnosing tuberculosis in the elderly can be difficult; in fact, elderly patients often have nonspecific clinical manifestations or co-morbidities, absent or attenuated fever response, and less common "classical" radiological presentations, which can cause delays in diagnosis. individuals over 65 years of age have a greater death rate than individuals under that age. Indeed, worldwide data from low-incidence nations indicates that almost 80% of deaths involve patients who are older than 65.It has been claimed that up to 51% of older patients die .Even though these death rates have been declining lately, they are still quite high

Pediatric, Tuberculosis, Gediatric, Rifampicin, Isoniazid

"ASSESSMENT OF TRETEMENT RESPONCES IN ANTIBIOTICS USED IN TRETEMENT OF TUBERCULOSIS FOR PEDIATRIC AND GERIATRIC", International Journal of Emerging Technologies and Innovative Research (www.jetir.org), ISSN:2349-5162, Vol.11, Issue 5, page no.c524-c535, May-2024, Available :http://www.jetir.org/papers/JETIR2405265.pdf

"ASSESSMENT OF TRETEMENT RESPONCES IN ANTIBIOTICS USED IN TRETEMENT OF TUBERCULOSIS FOR PEDIATRIC AND GERIATRIC", International Journal of Emerging Technologies and Innovative Research (www.jetir.org | UGC and issn Approved), ISSN:2349-5162, Vol.11, Issue 5, page no. ppc524-c535, May-2024, Available at : http://www.jetir.org/papers/JETIR2405265.pdf